Funamizu, Naotake <br/><br/>
Hydroxyurea decreases gemcitabine resistance in pancreatic carcinoma cells with highly expressed ribonucleotide reductase.  [electronic resource] 

 -  Pancreas  Jan 2012 
 - 107-13 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1536-4828 
<br/><br/><label>Standard No.: </label>10.1097/MPA.0b013e318224b5fb  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily G, Member 2<br/>ATP-Binding Cassette Transporters--genetics<br/>Antigens, CD<br/>Antineoplastic Agents--pharmacology<br/>Blotting, Western<br/>Cadherins--genetics<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Deoxycytidine--analogs & derivatives<br/>Dose-Response Relationship, Drug<br/>Drug Resistance, Neoplasm--drug effects<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Homeodomain Proteins--genetics<br/>Humans<br/>Hydroxyurea--pharmacology<br/>Multidrug Resistance-Associated Proteins--genetics<br/>Neoplasm Proteins--genetics<br/>Pancreatic Neoplasms--enzymology<br/>RNA Interference<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Ribonucleotide Reductases--antagonists & inhibitors<br/>Snail Family Transcription Factors<br/>Transcription Factors--genetics<br/>Vimentin--genetics<br/>Zinc Finger E-box-Binding Homeobox 1<br/>Gemcitabine